Asthma

Respiratory·MeSH: Asthma

Prevalence

8000.0 / 100K

Incidence

400.0 / 100K/yr

86 drugs in development·40 companies·77 clinical trials

Drug Pipeline by Phase

Approved(14)

Drug	Company
ANORO ELLIPTA	Innoviva, Inc. (INVA)
asmanex hfa	Organon & Co. (OGN)
breyna	Mylan II B.V. (MYL)
cromolyn	AGILE THERAPEUTICS INC (AGRX)
dulera	Organon & Co. (OGN)
hydrocortisone	Aptinyx Inc. (APTX)
methylprednisolone	Amneal Pharmaceuticals, Inc. (AMRX)
RELVAR/BREO ELLIPTA	Innoviva, Inc. (INVA)
RELVAR®/BREO® ELLIPTA®	Innoviva, Inc. (INVA)
theophylline	Amneal Pharmaceuticals, Inc. (AMRX)
Trelegy	Royalty Pharma plc (RPRX)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)
wixela inhub	Mylan II B.V. (MYL)
zafirlukast	DR REDDYS LABORATORIES LTD (RDY)

Phase 3(17)

Drug	Company
abs	Teva Pharmaceutical Industries Limited (TEVA)
asthma controller therapies	Sanofi (SNY)
asthma reliever therapies	Sanofi (SNY)
AZD8630	ASTRAZENECA PLC (AZN)
BDA MDI HFA 160/180 μg	ASTRAZENECA PLC (AZN)
BDA MDI HFO 160/180 μg	ASTRAZENECA PLC (AZN)
Budesonide	Novartis AG (NVS)
fp mdpi	Teva Pharmaceutical Industries Limited (TEVA)
fp/abs	Teva Pharmaceutical Industries Limited (TEVA)
GB-0895	Crinetics Pharmaceuticals, Inc. (CRNX)
lunsekimig	Sanofi (SNY)
qmf149	Novartis AG (NVS)
QMF149	Novartis AG (NVS)
Roflumilast	ASTRAZENECA PLC (AZN)
tev-56248	Teva Pharmaceutical Industries Limited (TEVA)
Tezepelumab	ASTRAZENECA PLC (AZN)
Tozorakimab	ASTRAZENECA PLC (AZN)

Phase 2(26)

Drug	Company
ATI-052	Aclaris Therapeutics, Inc. (ACRS)
budesonide/albuterol	Sanofi (SNY)
Budesonide/Albuterol	Sanofi (SNY)
budesonide/formoterol	Sanofi (SNY)
Budesonide/Formoterol	Sanofi (SNY)
fluticasone/salmeterol	Sanofi (SNY)
Fluticasone/Salmeterol	Sanofi (SNY)
glycopyrronium bromide 12.5ug	Novartis AG (NVS)
Glycopyrronium bromide 12.5ug	Novartis AG (NVS)
glycopyrronium bromide 25ug	Novartis AG (NVS)
Glycopyrronium bromide 25ug	Novartis AG (NVS)
ics-laba	Incyte Corp. (INCY)
INS1148	INSMED Inc (INSM)
KT-621	Kymera Therapeutics, Inc. (KYMR)
lunsekimig	Sanofi (SNY)
mn-221	MEDICINOVA INC (MNOV)
PF-07275315	PFIZER INC (PFE)
pur1900	Pulmatrix, Inc. (PULM)
rocatinlimab	AMGEN INC (AMGN)
rpt193	RAPT Therapeutics, Inc. (RAPT)
short-acting beta agonists	Sanofi (SNY)
Short-Acting Beta Agonists	Sanofi (SNY)
shr-1703	NYMOX PHARMACEUTICAL CORP (NYMXF)
verekitug	Upstream Bio, Inc. (UPB)
WIN378	Valneva SE (VALN)
zumilokibart	Apogee Therapeutics, Inc. (APGE)

Phase 1(10)

Drug	Company
amg 691	AMGEN INC (AMGN)
APG333	Apogee Therapeutics, Inc. (APGE)
APG777	Apogee Therapeutics, Inc. (APGE)
APG808	Apogee Therapeutics, Inc. (APGE)
ARO-MUC5AC	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CDX-622	Celldex Therapeutics, Inc. (CLDX)
gb-0895	Generate Biomedicines Inc. (GENB)
hbm9378	Q BioMed Inc. (QBIO)
salbutamol or levosalbutamol	Sanofi (SNY)
sar443765	Sanofi (SNY)

Preclinical(10)

Drug	Company
apg273	Apogee Therapeutics, Inc. (APGE)
cannabis-based	Raphael Pharmaceutical Inc. (RAPH)
cbd-x	Raphael Pharmaceutical Inc. (RAPH)
companion diagnostic tests for asthma	bioAffinity Technologies Inc. (BIAF)
generic flovent diskus	LANNETT CO INC (LCI)
ht-004	Hoth Therapeutics, Inc. (HOTH)
labp-73	Landos Biopharma, Inc. (LABP)
Oral IL-4R alpha antagonist	Protagonist Therapeutics, Inc (PTGX)
torudokimab	Zura Bio Ltd (ZURA)
zegocractin (oral, preclinical administration)	CalciMedica, Inc. (CALC)

Unknown(1)

Drug	Company
BDP/FF NEXThaler® 100/6 micrograms	Valneva SE (VALN)

BLA Filed(1)

Drug	Company
generic advair diskus	LANNETT CO INC (LCI)

Phase 1/Phase 2(1)

Drug	Company
ARO-RAGE	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Phase 4(6)

Drug	Company
albuterol emdpi ds	Teva Pharmaceutical Industries Limited (TEVA)
Benralizumab	ASTRAZENECA PLC (AZN)
cohort	ASTRAZENECA PLC (AZN)
Dupixent	REGENERON PHARMACEUTICALS, INC. (REGN)
ics/laba	REGENERON PHARMACEUTICALS, INC. (REGN)
omalizumab	GH Research PLC (GHRS)

BioSniper tracks 86 drugs in development for Asthma across 40 companies.

There are 77 clinical trials targeting Asthma tracked by BioSniper.

The estimated prevalence of Asthma is approximately 8000.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.